The evolving role of natural compounds in the medical treatment of uterine fibroids

M Ciebiera, M Ali, L Prince, T Jackson-Bey… - Journal of clinical …, 2020 - mdpi.com
Uterine fibroids (UFs) remain a significant health issue for many women, with a
disproportionate impact on women of color, likely due to both genetic and environmental …

Pharmacological treatment of uterine fibroids

RM Moroni, CS Vieira, RA Ferriani… - Annals of medical and …, 2014 - ajol.info
Uterine fibroids (UF) are common, benign gynecologic tumors, affecting one in three to four
women, with estimates of up to 80%, depending on the population studied. Their etiology is …

Alternative oral agents in prophylaxis and therapy of uterine fibroids—an up-to-date review

M Ciebiera, K Łukaszuk, B Męczekalski… - International Journal of …, 2017 - mdpi.com
Uterine fibroids (UFs) are the most common tumors of the female genital tract. The effect of
UFs on the quality of life and the overall cost of treatment are significant issues worldwide …

Evidence-based management of uterine fibroids with botanical drugs-a review

M Arip, VL Yap, M Rajagopal, M Selvaraja… - Frontiers in …, 2022 - frontiersin.org
Uterine fibroids (UFs) are a common benign gynecological tumor that affect the majority of
women over their lifetime. Several pharmacological agents are available to reduce the size …

Current and emerging treatment options for uterine fibroids

M Ali, M Ciebiera, M Wlodarczyk, S Alkhrait, E Maajid… - Drugs, 2023 - Springer
Uterine fibroids are the most common benign neoplasm of the female reproductive tract in
reproductive age women. Their prevalence is age dependent and can be detected in up to …

Contemporary management of uterine fibroids: focus on emerging medical treatments

SS Singh, L Belland - Current medical research and opinion, 2015 - Taylor & Francis
Objective: This review provides an overview of therapeutic options, with a specific focus on
the emerging role of medical options for UF management. Research design and methods …

Updated approaches for management of uterine fibroids

A Mas, M Tarazona, J Dasí Carrasco… - … journal of women's …, 2017 - Taylor & Francis
Uterine anatomy and uterine fibroids (UFs) characteristics have been classically considered
as almost a unique issue in gynecology and reproductive medicine. Nowadays, the …

Uterine fibroid therapy: the pharmacokinetic considerations

M Ali, A Al-Hendy - Expert opinion on drug metabolism & toxicology, 2018 - Taylor & Francis
Uterine fibroids (UFs, AKA; leiomyoma) are the most prevalent benign neoplastic threat in
reproductive age women. Ultrasound based epidemiological studies disclosed that 70− 80 …

[HTML][HTML] Uterine fibroids and current clinical challenges

SS Salama, GS Kılıç - Journal of the Turkish German Gynecological …, 2013 - ncbi.nlm.nih.gov
Uterine fibroids (UF) are the most common gynecological tumors in premenopausal women.
Hysterectomy remains the major and definitive therapeutic option. Minimally invasive …

Highlights on medical treatment of uterine fibroids

S Angioni, MN D'Alterio… - Current Pharmaceutical …, 2021 - ingentaconnect.com
Uterine fibroids (leiomyomas or myomas) are the most frequent benign tumors in women.
Heavy menstrual bleeding with resultant anemia, dysmenorrhea, chronic pelvic pain …